Neurocrine Biosciences, Inc.

-0.64 (-0.66%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)9.06B
Current PE24.84
Forward PE 43.9
2yr Forward PE 24.66
See more stats
Estimates Current Quarter
Revenue$296.84 Million
Adjusted EPS$0.60
See more estimates
10-Day MA$95.48
50-Day MA$93.96
200-Day MA$98.19
See more pivots

Neurocrine Biosciences, Inc. Stock, NASDAQ:NBIX

12780 El Camino Real, San Diego, California 92130
United States of America
Phone: +1.858.617.7600
Number of Employees: 845


Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The firm's product includes INGREZZA. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.